BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shin MD, Shukla S, Chung YH, Beiss V, Chan SK, Ortega-rivera OA, Wirth DM, Chen A, Sack M, Pokorski JK, Steinmetz NF. COVID-19 vaccine development and a potential nanomaterial path forward. Nat Nanotechnol 2020;15:646-55. [DOI: 10.1038/s41565-020-0737-y] [Cited by in Crossref: 197] [Cited by in F6Publishing: 279] [Article Influence: 98.5] [Reference Citation Analysis]
Number Citing Articles
1 Helmy SA, El-Morsi RM, Helmy SAM, El-Masry SM. Towards novel nano-based vaccine platforms for SARS-CoV-2 and its variants of concern: Advances, challenges and limitations. J Drug Deliv Sci Technol 2022;76:103762. [PMID: 36097606 DOI: 10.1016/j.jddst.2022.103762] [Reference Citation Analysis]
2 Dahri M, Sadeghi MM, Abolmaali SS. A computational study of metal-organic frameworks (MOFs) as potential nanostructures to combat SARS-CoV-2. Sci Rep 2022;12:15678. [PMID: 36127369 DOI: 10.1038/s41598-022-19845-7] [Reference Citation Analysis]
3 Hunckler MD, Levine AD. Navigating ethical challenges in the development and translation of biomaterials research. Front Bioeng Biotechnol 2022;10:949280. [DOI: 10.3389/fbioe.2022.949280] [Reference Citation Analysis]
4 Rastogi A, Singh A, Naik K, Mishra A, Chaudhary S, Manohar R, Singh Parmar A. A systemic review on liquid crystals, nanoformulations and its application for detection and treatment of SARS - CoV- 2 (COVID - 19). J Mol Liq 2022;362:119795. [PMID: 35832289 DOI: 10.1016/j.molliq.2022.119795] [Reference Citation Analysis]
5 Osouli-bostanabad K, Puliga S, Serrano DR, Bucchi A, Halbert G, Lalatsa A. Microfluidic Manufacture of Lipid-Based Nanomedicines. Pharmaceutics 2022;14:1940. [DOI: 10.3390/pharmaceutics14091940] [Reference Citation Analysis]
6 Monroy-borrego AG, Steinmetz NF. Three methods for inoculation of viral vectors into plants. Front Plant Sci 2022;13:963756. [DOI: 10.3389/fpls.2022.963756] [Reference Citation Analysis]
7 Panigrahi LL, Sahoo B, Arakha M. Nanotheranostics and its role in diagnosis, treatment and prevention of COVID-19. Front Mater Sci 2022;16:220611. [PMID: 35966717 DOI: 10.1007/s11706-022-0611-y] [Reference Citation Analysis]
8 Acosta-Coley I, Cervantes-Ceballos L, Tejeda-Benítez L, Sierra-Márquez L, Cabarcas-Montalvo M, García-Espiñeira M, Coronell-Rodríguez W, Arroyo-Salgado B. Vaccines platforms and COVID-19: what you need to know. Trop Dis Travel Med Vaccines 2022;8:20. [PMID: 35965345 DOI: 10.1186/s40794-022-00176-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Hassanzadeh P, Atyabi F, Dinarvand R. Nanobionics: From plant empowering to the infectious disease treatment. J Control Release 2022;349:890-901. [PMID: 35901860 DOI: 10.1016/j.jconrel.2022.07.028] [Reference Citation Analysis]
10 Kumar R, Dkhar DS, Kumari R, Divya, Mahapatra S, Dubey VK, Chandra P. Lipid based nanocarriers: Production techniques, concepts, and commercialization aspect. Journal of Drug Delivery Science and Technology 2022;74:103526. [DOI: 10.1016/j.jddst.2022.103526] [Reference Citation Analysis]
11 Zhou X, Wang H, Luo Y, Cui L, Guan Y, Zhang Y. Single-injection COVID-19 subunit vaccine elicits potent immune responses. Acta Biomaterialia 2022. [DOI: 10.1016/j.actbio.2022.08.006] [Reference Citation Analysis]
12 Rauf A, Abu-Izneid T, Khalil AA, Hafeez N, Olatunde A, Rahman M, Semwal P, Al-Awthan YS, Bahattab OS, Khan IN, Khan MA, Sharma R. Nanoparticles in clinical trials of COVID-19: An update. Int J Surg 2022;104:106818. [PMID: 35953020 DOI: 10.1016/j.ijsu.2022.106818] [Reference Citation Analysis]
13 Goharshadi EK, Goharshadi K, Moghayedi M. The use of nanotechnology in the fight against viruses: A critical review. Coordination Chemistry Reviews 2022;464:214559. [DOI: 10.1016/j.ccr.2022.214559] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Butt MH, Zaman M, Ahmad A, Khan R, Mallhi TH, Hasan MM, Khan YH, Hafeez S, Massoud EES, Rahman MH, Cavalu S. Appraisal for the Potential of Viral and Nonviral Vectors in Gene Therapy: A Review. Genes 2022;13:1370. [DOI: 10.3390/genes13081370] [Reference Citation Analysis]
15 Liao Z, Huang J, Lo PC, Lovell JF, Jin H, Yang K. Self-adjuvanting cancer nanovaccines. J Nanobiotechnology 2022;20:345. [PMID: 35883176 DOI: 10.1186/s12951-022-01545-z] [Reference Citation Analysis]
16 Cheng Y, Clark AE, Zhou J, He T, Li Y, Borum RM, Creyer MN, Xu M, Jin Z, Zhou J, Yim W, Wu Z, Fajtová P, O'Donoghue AJ, Carlin AF, Jokerst JV. Protease-Responsive Peptide-Conjugated Mitochondrial-Targeting AIEgens for Selective Imaging and Inhibition of SARS-CoV-2-Infected Cells. ACS Nano 2022. [PMID: 35878004 DOI: 10.1021/acsnano.2c03219] [Reference Citation Analysis]
17 Alqahtani MS, Abbas M, Abdulmuqeet M, Alqahtani AS, Alshahrani MY, Alsabaani A, Ramalingam M. Forecasting the Post-Pandemic Effects of the SARS-CoV-2 Virus Using the Bullwhip Phenomenon Alongside Use of Nanosensors for Disease Containment and Cure. Materials 2022;15:5078. [DOI: 10.3390/ma15145078] [Reference Citation Analysis]
18 Marzi A, Eder KM, Barroso Á, Wågbø AM, Mørch Ý, Hatletveit AR, Visnes T, Schmid RB, Klinkenberg G, Kemper B, Schnekenburger J. Interlaboratory evaluation of a digital holographic microscopy-based assay for label-free in vitro cytotoxicity testing of polymeric nanocarriers. Drug Deliv Transl Res 2022. [PMID: 35799027 DOI: 10.1007/s13346-022-01207-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Chen L, Li J. Mg2+ Ions Regulating 3WJ-PRNA to Construct Controllable RNA Nanoparticle Drug Delivery Platforms. Pharmaceutics 2022;14:1413. [DOI: 10.3390/pharmaceutics14071413] [Reference Citation Analysis]
20 Zhang M, Hussain A, Yang H, Zhang J, Liang XJ, Huang Y. mRNA-based modalities for infectious disease management. Nano Res 2022;:1-20. [PMID: 35818566 DOI: 10.1007/s12274-022-4627-5] [Reference Citation Analysis]
21 Krishnan N, Kubiatowicz LJ, Holay M, Zhou J, Fang RH, Zhang L. Bacterial membrane vesicles for vaccine applications. Adv Drug Deliv Rev 2022;185:114294. [PMID: 35436569 DOI: 10.1016/j.addr.2022.114294] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
22 Shi C, Wu M, Wang X, Yang K. Safety of COVID-19 vaccines in patients with non-communicable diseases: a protocol for systematic review and meta-analysis of randomised controlled trials. BMJ Open 2022;12:e057233. [PMID: 35613806 DOI: 10.1136/bmjopen-2021-057233] [Reference Citation Analysis]
23 Alva C, Vidakovic I, Lorber B, Schachner-nedherer A, Zettl M, Khinast J, Prassl R, Hsiao W. Can Liposomes Survive Inkjet Printing? The Effect of Jetting on Key Liposome Attributes for Drug Delivery Applications. J Pharm Innov. [DOI: 10.1007/s12247-022-09643-z] [Reference Citation Analysis]
24 Gao K, Wang R, Chen J, Cheng L, Frishcosy J, Huzumi Y, Qiu Y, Schluckbier T, Wei X, Wei GW. Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2. Chem Rev 2022. [PMID: 35594413 DOI: 10.1021/acs.chemrev.1c00965] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
25 Bogusz R, Nowakowska L, Majchrowska A, Patryn R, Pawlikowski J, Zagaja A, Kiciński P, Pacyna M, Puacz E. Convalescents' Reports on COVID-19 Experience-A Qualitative Study. Int J Environ Res Public Health 2022;19:6147. [PMID: 35627683 DOI: 10.3390/ijerph19106147] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Hassan J, Haigh C, Ahmed T, Uddin MJ, Das DB. Potential of Microneedle Systems for COVID-19 Vaccination: Current Trends and Challenges. Pharmaceutics 2022;14:1066. [DOI: 10.3390/pharmaceutics14051066] [Reference Citation Analysis]
27 Anand U, Carpena M, Kowalska-Góralska M, Garcia-Perez P, Sunita K, Bontempi E, Dey A, Prieto MA, Proćków J, Simal-Gandara J. Safer plant-based nanoparticles for combating antibiotic resistance in bacteria: A comprehensive review on its potential applications, recent advances, and future perspective. Sci Total Environ 2022;821:153472. [PMID: 35093375 DOI: 10.1016/j.scitotenv.2022.153472] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
28 Kang YF, Sun C, Sun J, Xie C, Zhuang Z, Xu HQ, Liu Z, Liu YH, Peng S, Yuan RY, Zhao JC, Zeng MS. Quadrivalent mosaic HexaPro-bearing nanoparticle vaccine protects against infection of SARS-CoV-2 variants. Nat Commun 2022;13:2674. [PMID: 35562337 DOI: 10.1038/s41467-022-30222-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Li M, Wang H, Tian L, Pang Z, Yang Q, Huang T, Fan J, Song L, Tong Y, Fan H. COVID-19 vaccine development: milestones, lessons and prospects. Signal Transduct Target Ther 2022;7:146. [PMID: 35504917 DOI: 10.1038/s41392-022-00996-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
30 Nazary Abrbekoh F, Salimi L, Saghati S, Amini H, Fathi Karkan S, Moharamzadeh K, Sokullu E, Rahbarghazi R. Application of microneedle patches for drug delivery; doorstep to novel therapies. J Tissue Eng 2022;13:204173142210853. [DOI: 10.1177/20417314221085390] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
31 Benedetto A, Kelley EG. Absorption of the [bmim][Cl] Ionic Liquid in DMPC Lipid Bilayers across Their Gel, Ripple, and Fluid Phases. J Phys Chem B 2022. [PMID: 35472281 DOI: 10.1021/acs.jpcb.2c00710] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Li Q, Xu R, Fan H, Xu J, Xu Y, Cao P, Zhang Y, Liang T, Zhang Y, Chen W, Wang Z, Wang L, Chen X. Smart Mushroom-Inspired Imprintable and Lightly Detachable (MILD) Microneedle Patterns for Effective COVID-19 Vaccination and Decentralized Information Storage. ACS Nano 2022. [PMID: 35451839 DOI: 10.1021/acsnano.1c10718] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Li J, Gao X, Wang Y, Xia T, Zhao Y, Meng H. Precision design of engineered nanomaterials to guide immune systems for disease treatment. Matter 2022;5:1162-91. [DOI: 10.1016/j.matt.2022.03.005] [Reference Citation Analysis]
34 Hussain A, Yang H, Zhang M, Liu Q, Alotaibi G, Irfan M, He H, Chang J, Liang XJ, Weng Y, Huang Y. mRNA vaccines for COVID-19 and diverse diseases. J Control Release 2022;345:314-33. [PMID: 35331783 DOI: 10.1016/j.jconrel.2022.03.032] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 14.0] [Reference Citation Analysis]
35 Rubab S, Khan MM, Uddin F, Abbas Bangash Y, Taqvi SAA. A Study on AI‐based Waste Management Strategies for the COVID‐19 Pandemic. ChemBioEng Reviews. [DOI: 10.1002/cben.202100044] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Tavares JL, Cavalcanti IDL, Santos Magalhães NS, Lira Nogueira MCDB. Nanotechnology and COVID-19: quo vadis? J Nanopart Res 2022;24. [DOI: 10.1007/s11051-022-05452-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Kim HJ, Seo SK, Park HY. Physical and chemical advances of synthetic delivery vehicles to enhance mRNA vaccine efficacy. Journal of Controlled Release 2022. [DOI: 10.1016/j.jconrel.2022.03.029] [Reference Citation Analysis]
38 Mabrouk MT, Huang WC, Martinez-Sobrido L, Lovell JF. Advanced Materials for SARS-CoV-2 Vaccines. Adv Mater 2022;34:e2107781. [PMID: 34894000 DOI: 10.1002/adma.202107781] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
39 Kiremitler NB, Kemerli MZ, Kayaci N, Karagoz S, Pekdemir S, Sarp G, Sanduvac S, Onses MS, Yilmaz E. Nanostructures for the Prevention, Diagnosis, and Treatment of SARS-CoV-2: A Review. ACS Appl Nano Mater 2022;5:6029-54. [DOI: 10.1021/acsanm.2c00181] [Reference Citation Analysis]
40 Huang M, Xiong E, Wang Y, Hu M, Yue H, Tian T, Zhu D, Liu H, Zhou X. Fast microwave heating-based one-step synthesis of DNA and RNA modified gold nanoparticles. Nat Commun 2022;13:968. [PMID: 35181653 DOI: 10.1038/s41467-022-28627-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
41 AlMalki FA, Albukhaty S, Alyamani AA, Khalaf MN, Thomas S. The relevant information about the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) using the five-question approach (when, where, what, why, and how) and its impact on the environment. Environ Sci Pollut Res Int 2022. [PMID: 35175517 DOI: 10.1007/s11356-022-18868-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
42 Alphandéry E. Nano dimensions/adjuvants in COVID-19 vaccines. J Mater Chem B 2022. [PMID: 35166754 DOI: 10.1039/d1tb02408f] [Reference Citation Analysis]
43 Wang Y, Chen‐mayfield T, Li Z, Younis MH, Cai W, Hu Q. Harnessing DNA for Immunotherapy: Cancer, Infectious Diseases, and Beyond. Adv Funct Materials. [DOI: 10.1002/adfm.202112273] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
44 Eder KM, Marzi A, Barroso Á, Ketelhut S, Kemper B, Schnekenburger J. Label-Free Digital Holographic Microscopy for In Vitro Cytotoxic Effect Quantification of Organic Nanoparticles. Cells 2022;11:644. [DOI: 10.3390/cells11040644] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
45 Liu T, Ju X, Hu Z, Xie R. Cobalt oxide confined in mesoporous SiO2 as effective catalyst for CO oxidation. Microporous and Mesoporous Materials 2022. [DOI: 10.1016/j.micromeso.2022.111733] [Reference Citation Analysis]
46 Berardi C, Lee ES, Wechtler H, Paolucci F. A vicious cycle of health (IN)equity: Migrant inclusion in light of COVID-19. Health Policy and Technology 2022. [DOI: 10.1016/j.hlpt.2022.100606] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
47 Mukai H, Ogawa K, Kato N, Kawakami S. Recent advances in lipid nanoparticles for delivery of nucleic acid, mRNA, and gene editing-based therapeutics. Drug Metabolism and Pharmacokinetics 2022. [DOI: 10.1016/j.dmpk.2022.100450] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
48 Mohammed SA, Shaaban EIA. Efficacious nanomedicine track toward combating COVID-19. Nanotechnology Reviews 2022;11:680-98. [DOI: 10.1515/ntrev-2022-0036] [Reference Citation Analysis]
49 Hunt NJ, Mccourt PAG, Kuncic Z, Le Couteur DG, Cogger VC. Opportunities and Challenges for Nanotherapeutics for the Aging Population. Front Nanotechnol 2022;4:832524. [DOI: 10.3389/fnano.2022.832524] [Reference Citation Analysis]
50 Hooftman A, O'Neill LAJ. Nanoparticle asymmetry shapes an immune response. Nature 2022;601:323-5. [PMID: 35046597 DOI: 10.1038/d41586-021-03806-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Mazayen ZM, Ghoneim AM, Elbatanony RS, Basalious EB, Bendas ER. Pharmaceutical nanotechnology: from the bench to the market. Futur J Pharm Sci 2022;8. [DOI: 10.1186/s43094-022-00400-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Sharma S. Role of nanomedicine in COVID-19 therapeutics. Nanomedicine (Lond) 2022. [PMID: 35012366 DOI: 10.2217/nnm-2021-0358] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Feng T, Nie C, Peng P, Lu H, Wang T, Li P, Huang W. Nanoagent-based theranostic strategies against human coronaviruses. Nano Res 2022;:1-15. [PMID: 35003529 DOI: 10.1007/s12274-021-3949-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Lopez-Cantu DO, Wang X, Carrasco-Magallanes H, Afewerki S, Zhang X, Bonventre JV, Ruiz-Esparza GU. From Bench to the Clinic: The Path to Translation of Nanotechnology-Enabled mRNA SARS-CoV-2 Vaccines. Nanomicro Lett 2022;14:41. [PMID: 34981278 DOI: 10.1007/s40820-021-00771-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
55 Tian S, Zheng N, Zu X, Wu G, Zhong J, Zhang J, Sheng L, Liu W, Wang C, Ge G, Han J, Zhao J, Li H, Zhang W. Integrated hepatic single-cell RNA sequencing and untargeted metabolomics reveals the immune and metabolic modulation of Qing-Fei-Pai-Du decoction in mice with coronavirus-induced pneumonia. Phytomedicine 2022;97:153922. [PMID: 35032732 DOI: 10.1016/j.phymed.2021.153922] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Jiang J, Mei J, Yi S, Feng C, Ma Y, Liu Y, Liu Y, Chen C. Tumor associated macrophage and microbe: The potential targets of tumor vaccine delivery. Adv Drug Deliv Rev 2022;180:114046. [PMID: 34767863 DOI: 10.1016/j.addr.2021.114046] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
57 Simnani FZ, Singh D, Kaur R. COVID-19 phase 4 vaccine candidates, effectiveness on SARS-CoV-2 variants, neutralizing antibody, rare side effects, traditional and nano-based vaccine platforms: a review. 3 Biotech 2022;12:15. [PMID: 34926119 DOI: 10.1007/s13205-021-03076-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
58 Yao QF, Zhu QY, Bu ZQ, Liu QY, Quan MX, Huang WT. DNA nanosensing systems for tunable detection of metal ions and molecular crypto-steganography. Biosens Bioelectron 2022;195:113645. [PMID: 34571483 DOI: 10.1016/j.bios.2021.113645] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
59 Santana-mederos D, Perez-nicado R, Climent Y, Rodriguez L, Ramirez BS, Perez-rodriguez S, Rodriguez M, Labrada C, Hernandez T, Diaz M, Orosa I, Ramirez U, Oliva R, Garrido R, Cardoso F, Landys M, Martinez R, Gonzalez H, Hernandez T, Ochoa-azze R, Perez JL, Enriquez J, Gonzalez N, Infante Y, Espinosa LA, Ramos Y, González LJ, Valenzuela C, Casadesus AV, Fernandez B, Rojas G, Pérez-massón B, Tundidor Y, Bermudez E, Plasencia CA, Boggiano T, Ojito E, Chiodo F, Fernandez S, Paquet F, Fang C, Chen G, Rivera DG, Valdes-balbin Y, Garcia-rivera D, Verez Bencomo V. A COVID-19 vaccine candidate composed of the SARS-CoV-2 RBD dimer and Neisseria meningitidis outer membrane vesicles. RSC Chem Biol . [DOI: 10.1039/d1cb00200g] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
60 Suwardi A, Wang F, Xue K, Han MY, Teo P, Wang P, Wang S, Liu Y, Ye E, Li Z, Loh XJ. Machine Learning-Driven Biomaterials Evolution. Adv Mater 2022;34:e2102703. [PMID: 34617632 DOI: 10.1002/adma.202102703] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
61 Shi K, Liu Y, Zhang Q, Ran CP, Hou J, Zhang Y, Wang XB. Severe Type of COVID-19: Pathogenesis, Warning Indicators and Treatment. Chin J Integr Med 2022;28:3-11. [PMID: 34962616 DOI: 10.1007/s11655-021-3313-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
62 Carmona-ribeiro AM. Supramolecular Nanostructures for Vaccines. Biomimetics 2022;7:6. [DOI: 10.3390/biomimetics7010006] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
63 Modi S, Prajapati R, Inwati GK, Deepa N, Tirth V, Yadav VK, Yadav KK, Islam S, Gupta P, Kim D, Jeon B. Recent Trends in Fascinating Applications of Nanotechnology in Allied Health Sciences. Crystals 2022;12:39. [DOI: 10.3390/cryst12010039] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
64 Safer AM, Leporatti S. Chitosan Nanoparticles for Antiviral Drug Delivery: A Novel Route for COVID-19 Treatment. Int J Nanomedicine 2021;16:8141-58. [PMID: 34949922 DOI: 10.2147/IJN.S332385] [Reference Citation Analysis]
65 Shin MD, Hochberg JD, Pokorski JK, Steinmetz NF. Bioconjugation of Active Ingredients to Plant Viral Nanoparticles Is Enhanced by Preincubation with a Pluronic F127 Polymer Scaffold. ACS Appl Mater Interfaces 2021;13:59618-32. [PMID: 34890195 DOI: 10.1021/acsami.1c13183] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
66 Huang S, Zhu Y, Zhang L, Zhang Z. Recent Advances in Delivery Systems for Genetic and Other Novel Vaccines. Adv Mater 2021;:e2107946. [PMID: 34914144 DOI: 10.1002/adma.202107946] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
67 Abisoye-Ogunniyan A, Carrano IM, Weilhammer DR, Gilmore SF, Fischer NO, Pal S, de la Maza LM, Coleman MA, Rasley A. A Survey of Preclinical Studies Evaluating Nanoparticle-Based Vaccines Against Non-Viral Sexually Transmitted Infections. Front Pharmacol 2021;12:768461. [PMID: 34899322 DOI: 10.3389/fphar.2021.768461] [Reference Citation Analysis]
68 Goscianska J, Freund R, Wuttke S. Nanoscience versus Viruses: The SARS‐CoV‐2 Case. Adv Funct Materials 2022;32:2107826. [DOI: 10.1002/adfm.202107826] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
69 Li X, Huang Y, Jin Q, Ji J. Mixed-charge modification as a robust method to realize the antiviral ability of gold nanoparticles in a high protein environment. Nanoscale 2021;13:19857-63. [PMID: 34825689 DOI: 10.1039/d1nr06756g] [Reference Citation Analysis]
70 Kara A, Vassiliadou A, Ongoren B, Keeble W, Hing R, Lalatsa A, Serrano DR. Engineering 3D Printed Microfluidic Chips for the Fabrication of Nanomedicines. Pharmaceutics 2021;13:2134. [PMID: 34959415 DOI: 10.3390/pharmaceutics13122134] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
71 Zhu W, Wei Z, Han C, Weng X. Nanomaterials as Promising Theranostic Tools in Nanomedicine and Their Applications in Clinical Disease Diagnosis and Treatment. Nanomaterials (Basel) 2021;11:3346. [PMID: 34947695 DOI: 10.3390/nano11123346] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
72 Gao K, Wang R, Chen J, Tepe JJ, Huang F, Wei GW. Perspectives on SARS-CoV-2 Main Protease Inhibitors. J Med Chem 2021;64:16922-55. [PMID: 34798775 DOI: 10.1021/acs.jmedchem.1c00409] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
73 Roh H, Yoon YJ, Park JS, Kang DH, Kwak SM, Lee BC, Im M. Fabrication of High-Density Out-of-Plane Microneedle Arrays with Various Heights and Diverse Cross-Sectional Shapes. Nanomicro Lett 2021;14:24. [PMID: 34888758 DOI: 10.1007/s40820-021-00778-1] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
74 Dong C, Wang B. Engineered Nanoparticulate Vaccines to Combat Recurring and Pandemic Influenza Threats. Advanced NanoBiomed Research 2022;2:2100122. [DOI: 10.1002/anbr.202100122] [Reference Citation Analysis]
75 Cordeiro AS, Patil-Sen Y, Shivkumar M, Patel R, Khedr A, Elsawy MA. Nanovaccine Delivery Approaches and Advanced Delivery Systems for the Prevention of Viral Infections: From Development to Clinical Application. Pharmaceutics 2021;13:2091. [PMID: 34959372 DOI: 10.3390/pharmaceutics13122091] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
76 Ding Y, Li Z, Jaklenec A, Hu Q. Vaccine delivery systems toward lymph nodes. Adv Drug Deliv Rev 2021;179:113914. [PMID: 34363861 DOI: 10.1016/j.addr.2021.113914] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
77 Manikkath J, Subramony JA. Toward closed-loop drug delivery: Integrating wearable technologies with transdermal drug delivery systems. Adv Drug Deliv Rev 2021;179:113997. [PMID: 34634396 DOI: 10.1016/j.addr.2021.113997] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
78 Tobin E, Brenner S. Nanotechnology Fundamentals Applied to Clinical Infectious Diseases and Public Health. Open Forum Infect Dis 2021;8:ofab583. [PMID: 34988245 DOI: 10.1093/ofid/ofab583] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
79 Kumbhar PS, Pandya AK, Manjappa AS, Disouza JI, Patravale VB. Carbohydrates-based diagnosis, prophylaxis and treatment of infectious diseases: Special emphasis on COVID-19. Carbohydrate Polymer Technologies and Applications 2021;2:100052. [DOI: 10.1016/j.carpta.2021.100052] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
80 Miao YB, Lin YJ, Chen KH, Luo PK, Chuang SH, Yu YT, Tai HM, Chen CT, Lin KJ, Sung HW. Engineering Nano- and Microparticles as Oral Delivery Vehicles to Promote Intestinal Lymphatic Drug Transport. Adv Mater 2021;33:e2104139. [PMID: 34596293 DOI: 10.1002/adma.202104139] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
81 Lim S, Salentinig S. Protein nanocage-stabilized Pickering emulsions. Current Opinion in Colloid & Interface Science 2021;56:101485. [DOI: 10.1016/j.cocis.2021.101485] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
82 Wang Y, Hao Y, Fa S, Zheng W, Yuan C, Wang W. Nanomedicine for the Diagnosis and Therapy of COVID-19. Front Bioeng Biotechnol 2021;9:758121. [PMID: 34805116 DOI: 10.3389/fbioe.2021.758121] [Reference Citation Analysis]
83 Vu MN, Kelly HG, Kent SJ, Wheatley AK. Current and future nanoparticle vaccines for COVID-19. EBioMedicine 2021;74:103699. [PMID: 34801965 DOI: 10.1016/j.ebiom.2021.103699] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
84 Melamed JR, Hajj KA, Chaudhary N, Strelkova D, Arral ML, Pardi N, Alameh MG, Miller JB, Farbiak L, Siegwart DJ, Weissman D, Whitehead KA. Lipid nanoparticle chemistry determines how nucleoside base modifications alter mRNA delivery. J Control Release 2021;341:206-14. [PMID: 34801660 DOI: 10.1016/j.jconrel.2021.11.022] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
85 Stentz R, Miquel-Clopés A, Carding SR. Production, Isolation, and Characterization of Bioengineered Bacterial Extracellular Membrane Vesicles Derived from Bacteroides thetaiotaomicron and Their Use in Vaccine Development. Methods Mol Biol 2022;2414:171-90. [PMID: 34784038 DOI: 10.1007/978-1-0716-1900-1_11] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
86 Ortega-Rivera OA, Shukla S, Shin MD, Chen A, Beiss V, Moreno-Gonzalez MA, Zheng Y, Clark AE, Carlin AF, Pokorski JK, Steinmetz NF. Cowpea Mosaic Virus Nanoparticle Vaccine Candidates Displaying Peptide Epitopes Can Neutralize the Severe Acute Respiratory Syndrome Coronavirus. ACS Infect Dis 2021;7:3096-110. [PMID: 34672530 DOI: 10.1021/acsinfecdis.1c00410] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
87 Machtakova M, Thérien-Aubin H, Landfester K. Polymer nano-systems for the encapsulation and delivery of active biomacromolecular therapeutic agents. Chem Soc Rev 2021. [PMID: 34762084 DOI: 10.1039/d1cs00686j] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 12.0] [Reference Citation Analysis]
88 Niculescu AG, Grumezescu AM. Polymer-Based Nanosystems-A Versatile Delivery Approach. Materials (Basel) 2021;14:6812. [PMID: 34832213 DOI: 10.3390/ma14226812] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
89 Luo WC, O'Reilly Beringhs A, Kim R, Zhang W, Patel SM, Bogner RH, Lu X. Impact of formulation on the quality and stability of freeze-dried nanoparticles. Eur J Pharm Biopharm 2021;169:256-67. [PMID: 34732383 DOI: 10.1016/j.ejpb.2021.10.014] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
90 Duan Y, Wang S, Zhang Q, Gao W, Zhang L. Nanoparticle approaches against SARS-CoV-2 infection. Curr Opin Solid State Mater Sci 2021;25:100964. [PMID: 34729031 DOI: 10.1016/j.cossms.2021.100964] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
91 Golan MS, Mahoney E, Trump B, Linkov I. Resilience and efficiency for the nanotechnology supply chains underpinning COVID-19 vaccine development. Curr Opin Chem Eng 2021;34:100759. [PMID: 34722136 DOI: 10.1016/j.coche.2021.100759] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
92 Sun J, Liu F, Yu W, Fu D, Jiang Q, Mo F, Wang X, Shi T, Wang F, Pang DW, Liu X. Visualization of Vaccine Dynamics with Quantum Dots for Immunotherapy. Angew Chem Int Ed Engl 2021;60:24275-83. [PMID: 34476884 DOI: 10.1002/anie.202111093] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
93 Kim E, Lim EK, Park G, Park C, Lim JW, Lee H, Na W, Yeom M, Kim J, Song D, Haam S. Advanced Nanomaterials for Preparedness Against (Re-)Emerging Viral Diseases. Adv Mater 2021;33:e2005927. [PMID: 33586180 DOI: 10.1002/adma.202005927] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
94 Weiss P. Microneedle Makers Seek to Engineer a Better Shot. Engineering 2021. [DOI: 10.1016/j.eng.2021.11.010] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
95 Ren E, Liu C, Lv P, Wang J, Liu G. Genetically Engineered Cellular Membrane Vesicles as Tailorable Shells for Therapeutics. Adv Sci (Weinh) 2021;8:e2100460. [PMID: 34494387 DOI: 10.1002/advs.202100460] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
96 Chaudhary JK, Yadav R, Chaudhary PK, Maurya A, Kant N, Rugaie OA, Haokip HR, Yadav D, Roshan R, Prasad R, Chatrath A, Singh D, Jain N, Dhamija P. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity. Cells 2021;10:2949. [PMID: 34831172 DOI: 10.3390/cells10112949] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
97 Muhammad W, Zhai Z, Wang S, Gao C. Inflammation-modulating nanoparticles for pneumonia therapy. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2021;:e1763. [PMID: 34713969 DOI: 10.1002/wnan.1763] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
98 Ai X, Wang D, Honko A, Duan Y, Gavrish I, Fang RH, Griffiths A, Gao W, Zhang L. Surface Glycan Modification of Cellular Nanosponges to Promote SARS-CoV-2 Inhibition. J Am Chem Soc 2021;143:17615-21. [PMID: 34647745 DOI: 10.1021/jacs.1c07798] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
99 Frederickson ME, Reese AT. Microbial Ecology and Evolution Are Essential for Understanding Pandemics. mBio 2021;12:e0214421. [PMID: 34579579 DOI: 10.1128/mBio.02144-21] [Reference Citation Analysis]
100 Park S, Choi YK, Kim S, Lee J, Im W. CHARMM-GUI Membrane Builder for Lipid Nanoparticles with Ionizable Cationic Lipids and PEGylated Lipids. J Chem Inf Model 2021;61:5192-202. [PMID: 34546048 DOI: 10.1021/acs.jcim.1c00770] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
101 Zhang YN, Paynter J, Sou C, Fourfouris T, Wang Y, Abraham C, Ngo T, Zhang Y, He L, Zhu J. Mechanism of a COVID-19 nanoparticle vaccine candidate that elicits a broadly neutralizing antibody response to SARS-CoV-2 variants. Sci Adv 2021;7:eabj3107. [PMID: 34669468 DOI: 10.1126/sciadv.abj3107] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
102 Al-douri Y, Mansoob Khan M, Robert Jennings J, Abd El-rehim AF. Nanomaterial-based biosensors for COVID-19 detection. Critical Reviews in Solid State and Materials Sciences. [DOI: 10.1080/10408436.2021.1989665] [Reference Citation Analysis]
103 Dube A, Egieyeh S, Balogun M. A Perspective on Nanotechnology and COVID-19 Vaccine Research and Production in South Africa. Viruses 2021;13:2095. [PMID: 34696526 DOI: 10.3390/v13102095] [Reference Citation Analysis]
104 Hristov DR, Gomez-Marquez J, Wade D, Hamad-Schifferli K. SARS-CoV-2 and approaches for a testing and diagnostic strategy. J Mater Chem B 2021;9:8157-73. [PMID: 34494642 DOI: 10.1039/d1tb00674f] [Reference Citation Analysis]
105 Prasad M, Kumar R, Buragohain L, Kumari A, Ghosh M. Organoid Technology: A Reliable Developmental Biology Tool for Organ-Specific Nanotoxicity Evaluation. Front Cell Dev Biol 2021;9:696668. [PMID: 34631696 DOI: 10.3389/fcell.2021.696668] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
106 Kamat S, Kumari M, Jayabaskaran C. Nano-engineered tools in the diagnosis, therapeutics, prevention, and mitigation of SARS-CoV-2. J Control Release 2021;338:813-36. [PMID: 34478750 DOI: 10.1016/j.jconrel.2021.08.046] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
107 Gao Y, Zhao Q, Dong H, Xiao M, Huang X, Wu X. Developing Acid-Responsive Glyco-Nanoplatform Based Vaccines for Enhanced Cytotoxic T-lymphocyte Responses Against Cancer and SARS-CoV-2. Adv Funct Mater 2021;31:2105059. [PMID: 34512228 DOI: 10.1002/adfm.202105059] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
108 Soni SS, Rodell CB. Polymeric materials for immune engineering: Molecular interaction to biomaterial design. Acta Biomater 2021;133:139-52. [PMID: 33484909 DOI: 10.1016/j.actbio.2021.01.016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
109 Jawad B, Adhikari P, Podgornik R, Ching WY. Key Interacting Residues between RBD of SARS-CoV-2 and ACE2 Receptor: Combination of Molecular Dynamics Simulation and Density Functional Calculation. J Chem Inf Model 2021;61:4425-41. [PMID: 34428371 DOI: 10.1021/acs.jcim.1c00560] [Cited by in Crossref: 1] [Cited by in F6Publishing: 28] [Article Influence: 1.0] [Reference Citation Analysis]
110 Shuai Q, Zhu F, Zhao M, Yan Y. mRNA delivery via non-viral carriers for biomedical applications. Int J Pharm 2021;607:121020. [PMID: 34416327 DOI: 10.1016/j.ijpharm.2021.121020] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
111 Zhang W, Zhang Y, Min Z, Mo J, Ju Z, Guan W, Zeng B, Liu Y, Chen J, Zhang Q, Li H, Zeng C, Wei Y, Chan GC. COVID19db: a comprehensive database platform to discover potential drugs and targets of COVID-19 at whole transcriptomic scale. Nucleic Acids Res 2021:gkab850. [PMID: 34554255 DOI: 10.1093/nar/gkab850] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
112 Das A, Ali N. Nanovaccine: an emerging strategy. Expert Rev Vaccines 2021;20:1273-90. [PMID: 34550859 DOI: 10.1080/14760584.2021.1984890] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
113 Ortega-Rivera OA, Shin MD, Chen A, Beiss V, Moreno-Gonzalez MA, Lopez-Ramirez MA, Reynoso M, Wang H, Hurst BL, Wang J, Pokorski JK, Steinmetz NF. Trivalent Subunit Vaccine Candidates for COVID-19 and Their Delivery Devices. J Am Chem Soc 2021;143:14748-65. [PMID: 34490778 DOI: 10.1021/jacs.1c06600] [Cited by in Crossref: 1] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
114 Wang L, Wang X, Yang F, Liu Y, Meng L, Pang Y, Zhang M, Chen F, Pan C, Lin S, Zhu X, Leong KW, Liu J. Systemic antiviral immunization by virus-mimicking nanoparticles-decorated erythrocytes. Nano Today 2021;40:101280. [PMID: 34512795 DOI: 10.1016/j.nantod.2021.101280] [Cited by in Crossref: 1] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
115 Zhu J, Ananthaswamy N, Jain S, Batra H, Tang WC, Lewry DA, Richards ML, David SA, Kilgore PB, Sha J, Drelich A, Tseng CK, Chopra AK, Rao VB. A universal bacteriophage T4 nanoparticle platform to design multiplex SARS-CoV-2 vaccine candidates by CRISPR engineering. Sci Adv 2021;7:eabh1547. [PMID: 34516878 DOI: 10.1126/sciadv.abh1547] [Cited by in Crossref: 1] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
116 Oliveira EA, Oliveira MCL, Martelli DB, Colosimo EA, Silva LR, Lanza K, Martelli-Júnior H, Simões E Silva AC. COVID-19 pandemic and the answer of science: a year in review. An Acad Bras Cienc 2021;93:e20210543. [PMID: 34495206 DOI: 10.1590/0001-3765202120210543] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
117 Bhutta ZA, Kanwal A, Ali M, Kulyar MF, Yao W, Shoaib M, Ashar A, Mahfooz A, Ijaz M, Ijaz N, Asif M, Nawaz S, Mahfooz MR, Kanwal T. Emerging nanotechnology role in the development of innovative solutions against COVID-19 pandemic. Nanotechnology 2021;32. [PMID: 34320471 DOI: 10.1088/1361-6528/ac189e] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
118 Yayehrad AT, Siraj EA, Wondie GB, Alemie AA, Derseh MT, Ambaye AS. Could Nanotechnology Help to End the Fight Against COVID-19? Review of Current Findings, Challenges and Future Perspectives. Int J Nanomedicine 2021;16:5713-43. [PMID: 34465991 DOI: 10.2147/IJN.S327334] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
119 Pan C, Yue H, Zhu L, Ma GH, Wang HL. Prophylactic vaccine delivery systems against epidemic infectious diseases. Adv Drug Deliv Rev 2021;176:113867. [PMID: 34280513 DOI: 10.1016/j.addr.2021.113867] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
120 Colombani T, Eggermont LJ, Rogers ZJ, McKay LGA, Avena LE, Johnson RI, Storm N, Griffiths A, Bencherif SA. Biomaterials and Oxygen Join Forces to Shape the Immune Response and Boost COVID-19 Vaccines. Adv Sci (Weinh) 2021;8:2100316. [PMID: 34580619 DOI: 10.1002/advs.202100316] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
121 Durán-Lobato M, López-Estévez AM, Cordeiro AS, Dacoba TG, Crecente-Campo J, Torres D, Alonso MJ. Nanotechnologies for the delivery of biologicals: Historical perspective and current landscape. Adv Drug Deliv Rev 2021;176:113899. [PMID: 34314784 DOI: 10.1016/j.addr.2021.113899] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
122 Garg SS, Sharma A, Gupta J. Immunomodulation and immunotherapeutics of COVID-19. Clin Immunol 2021;231:108842. [PMID: 34461289 DOI: 10.1016/j.clim.2021.108842] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
123 Polla Ravi S, Shamiya Y, Chakraborty A, Elias C, Paul A. Biomaterials, biological molecules, and polymers in developing vaccines. Trends Pharmacol Sci 2021;42:813-28. [PMID: 34454774 DOI: 10.1016/j.tips.2021.07.006] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
124 Shahzamani K, Mahmoudian F, Ahangarzadeh S, Ranjbar MM, Beikmohammadi L, Bahrami S, Mohammadi E, Esfandyari S, Alibakhshi A, Javanmard SH. Vaccine design and delivery approaches for COVID-19. Int Immunopharmacol 2021;100:108086. [PMID: 34454291 DOI: 10.1016/j.intimp.2021.108086] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
125 Volpatti LR, Wallace RP, Cao S, Raczy MM, Wang R, Gray LT, Alpar AT, Briquez PS, Mitrousis N, Marchell TM, Sasso MS, Nguyen M, Mansurov A, Budina E, Solanki A, Watkins EA, Schnorenberg MR, Tremain AC, Reda JW, Nicolaescu V, Furlong K, Dvorkin S, Yu SS, Manicassamy B, LaBelle JL, Tirrell MV, Randall G, Kwissa M, Swartz MA, Hubbell JA. Polymersomes Decorated with the SARS-CoV-2 Spike Protein Receptor-Binding Domain Elicit Robust Humoral and Cellular Immunity. ACS Cent Sci 2021;7:1368-80. [PMID: 34466656 DOI: 10.1021/acscentsci.1c00596] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
126 Hanna J, Tipparaju P, Mulherkar T, Lin E, Mischley V, Kulkarni R, Bolton A, Byrareddy SN, Jain P. Risk Factors Associated with the Clinical Outcomes of COVID-19 and Its Variants in the Context of Cytokine Storm and Therapeutics/Vaccine Development Challenges. Vaccines (Basel) 2021;9:938. [PMID: 34452063 DOI: 10.3390/vaccines9080938] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
127 Homaeigohar S, Liu Q, Kordbacheh D. Biomedical Applications of Antiviral Nanohybrid Materials Relating to the COVID-19 Pandemic and Other Viral Crises. Polymers (Basel) 2021;13:2833. [PMID: 34451371 DOI: 10.3390/polym13162833] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
128 Yaqinuddin A, Shafqat A, Kashir J, Alkattan K. Effect of SARS-CoV-2 Mutations on the Efficacy of Antibody Therapy and Response to Vaccines. Vaccines (Basel) 2021;9:914. [PMID: 34452039 DOI: 10.3390/vaccines9080914] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
129 Huang X, Sun X, Wang W, Shen Q, Shen Q, Tang X, Shao J. Nanoscale metal-organic frameworks for tumor phototherapy. J Mater Chem B 2021;9:3756-77. [PMID: 33870980 DOI: 10.1039/d1tb00349f] [Cited by in Crossref: 2] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
130 Zare M, Thomas V, Ramakrishna S. Nanoscience and quantum science-led biocidal and antiviral strategies. J Mater Chem B 2021. [PMID: 34378553 DOI: 10.1039/d0tb02639e] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
131 Cho BG, Gautam S, Peng W, Huang Y, Goli M, Mechref Y. Direct Comparison of N-Glycans and Their Isomers Derived from Spike Glycoprotein 1 of MERS-CoV, SARS-CoV-1, and SARS-CoV-2. J Proteome Res 2021. [PMID: 34369795 DOI: 10.1021/acs.jproteome.1c00323] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
132 Wang PW, Lee WT, Wu YN, Shieh DB. Opportunities for Nanomedicine in Clostridioides difficile Infection. Antibiotics (Basel) 2021;10:948. [PMID: 34438998 DOI: 10.3390/antibiotics10080948] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
133 Kaushik SK, Bobdey S, Faujdar DS, Anand V, Kumar Yadav A. Coronavirus disease 2019 vaccines: perspectives and update. Med J Armed Forces India 2021;77:S245-9. [PMID: 34334888 DOI: 10.1016/j.mjafi.2021.04.003] [Reference Citation Analysis]
134 Mi Z, Chen CB, Tan HQ, Dou Y, Yang C, Turaga SP, Ren M, Vajandar SK, Yuen GH, Osipowicz T, Watt F, Bettiol AA. Quantifying nanodiamonds biodistribution in whole cells with correlative iono-nanoscopy. Nat Commun 2021;12:4657. [PMID: 34341359 DOI: 10.1038/s41467-021-25004-9] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
135 Li M, Li S, Huang Y, Chen H, Zhang S, Zhang Z, Wu W, Zeng X, Zhou B, Li B. Secreted Expression of mRNA-Encoded Truncated ACE2 Variants for SARS-CoV-2 via Lipid-Like Nanoassemblies. Adv Mater 2021;33:e2101707. [PMID: 34278613 DOI: 10.1002/adma.202101707] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
136 Chen Y, Alba M, Tieu T, Tong Z, Minhas RS, Rudd D, Voelcker NH, Cifuentes-rius A, Elnathan R. Engineering Micro–Nanomaterials for Biomedical Translation. Adv NanoBio Res 2021;1:2100002. [DOI: 10.1002/anbr.202100002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
137 Dai Z, Li J, Lin Y, Wang Z, Huang Y. Facile Construction of a Solely-DNA-Based System for Targeted Delivery of Nucleic Acids. Nanomaterials (Basel) 2021;11:1967. [PMID: 34443796 DOI: 10.3390/nano11081967] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
138 Seidi F, Deng C, Zhong Y, Liu Y, Huang Y, Li C, Xiao H. Functionalized Masks: Powerful Materials against COVID-19 and Future Pandemics. Small 2021;17:e2102453. [PMID: 34319644 DOI: 10.1002/smll.202102453] [Cited by in Crossref: 3] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
139 Malden S, Heeney C, Bates DW, Sheikh A. Utilizing health information technology in the treatment and management of patients during the COVID-19 pandemic: Lessons from international case study sites. J Am Med Inform Assoc 2021;28:1555-63. [PMID: 33713131 DOI: 10.1093/jamia/ocab057] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
140 Zhang YN, Paynter J, Sou C, Fourfouris T, Wang Y, Abraham C, Ngo T, Zhang Y, He L, Zhu J. Mechanism of a COVID-19 nanoparticle vaccine candidate that elicits a broadly neutralizing antibody response to SARS-CoV-2 variants. bioRxiv 2021:2021. [PMID: 33791704 DOI: 10.1101/2021.03.26.437274] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
141 Zhang W, Jia Q, Teng Y, Yang M, Zhang H, Zhang XE, Wang P, Ge J, Cao S, Li F. An Ultrastable Virus-Like Particle with a Carbon Dot Core and Expanded Sequence Plasticity. Small 2021;17:e2101717. [PMID: 34302443 DOI: 10.1002/smll.202101717] [Reference Citation Analysis]
142 Hu J, Stojanović J, Yasamineh S, Yasamineh P, Karuppannan SK, Hussain Dowlath MJ, Serati-Nouri H. The potential use of microRNAs as a therapeutic strategy for SARS-CoV-2 infection. Arch Virol 2021;166:2649-72. [PMID: 34278528 DOI: 10.1007/s00705-021-05152-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
143 Pham MT, Yang AJ, Kao MS, Gankhuyag U, Zayabaatar E, Jin SC, Huang CM. Gut probiotic Lactobacillus rhamnosus attenuates PDE4B-mediated interleukin-6 induced by SARS-CoV-2 membrane glycoprotein. J Nutr Biochem 2021;98:108821. [PMID: 34271099 DOI: 10.1016/j.jnutbio.2021.108821] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
144 Bobbala S, Vincent MP, Scott EA. Just add water: hydratable, morphologically diverse nanocarrier powders for targeted delivery. Nanoscale 2021;13:11349-59. [PMID: 34160529 DOI: 10.1039/d1nr02188e] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
145 Rasmi Y, Saloua KS, Nemati M, Choi JR. Recent Progress in Nanotechnology for COVID-19 Prevention, Diagnostics and Treatment. Nanomaterials (Basel) 2021;11:1788. [PMID: 34361174 DOI: 10.3390/nano11071788] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
146 Lu L, Xiong W, Mu J, Zhang Q, Zhang H, Zou L, Li W, He L, Sander JW, Zhou D. The potential neurological effect of the COVID-19 vaccines: A review. Acta Neurol Scand 2021;144:3-12. [PMID: 33779985 DOI: 10.1111/ane.13417] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 32.0] [Reference Citation Analysis]
147 Qamar SUR. Nanocomposites: Potential therapeutic agents for the diagnosis and treatment of infectious diseases and cancer. Colloid and Interface Science Communications 2021;43:100463. [DOI: 10.1016/j.colcom.2021.100463] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
148 Ayele AG, Enyew EF, Kifle ZD. Roles of existing drug and drug targets for COVID-19 management. Metabol Open 2021;11:100103. [PMID: 34222852 DOI: 10.1016/j.metop.2021.100103] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
149 Zarei M, Rahimi K, Hassanzadeh K, Abdi M, Hosseini V, Fathi A, Kakaei K. From the environment to the cells: An overview on pivotal factors which affect spreading and infection in COVID-19 pandemic. Environ Res 2021;201:111555. [PMID: 34197816 DOI: 10.1016/j.envres.2021.111555] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
150 Rodrigues ICP, Campo KN, Arns CW, Gabriel LP, Webster TJ, Lopes ÉSN. From Bulk to Nanoparticles: An Overview of Antiviral Materials, Its Mechanisms, and Applications. Part Part Syst Charact 2021;38:2100044. [DOI: 10.1002/ppsc.202100044] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
151 Hasanzadeh A, Alamdaran M, Ahmadi S, Nourizadeh H, Bagherzadeh MA, Mofazzal Jahromi MA, Simon P, Karimi M, Hamblin MR. Nanotechnology against COVID-19: Immunization, diagnostic and therapeutic studies. J Control Release 2021;336:354-74. [PMID: 34175366 DOI: 10.1016/j.jconrel.2021.06.036] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
152 Geoghegan JL, Douglas J, Ren X, Storey M, Hadfield J, Silander OK, Freed NE, Jelley L, Jefferies S, Sherwood J, Paine S, Huang S, Sporle A, Baker MG, Murdoch DR, Drummond AJ, Welch D, Simpson CR, French N, Holmes EC, de Ligt J. Use of Genomics to Track Coronavirus Disease Outbreaks, New Zealand. Emerg Infect Dis 2021;27:1317-22. [PMID: 33900175 DOI: 10.3201/eid2705.204579] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
153 Li Z, Wang Z, Dinh PC, Zhu D, Popowski KD, Lutz H, Hu S, Lewis MG, Cook A, Andersen H, Greenhouse J, Pessaint L, Lobo LJ, Cheng K. Cell-mimicking nanodecoys neutralize SARS-CoV-2 and mitigate lung injury in a non-human primate model of COVID-19. Nat Nanotechnol 2021;16:942-51. [PMID: 34140674 DOI: 10.1038/s41565-021-00923-2] [Cited by in F6Publishing: 35] [Reference Citation Analysis]
154 Daemi HB, Kulyar MF, He X, Li C, Karimpour M, Sun X, Zou Z, Jin M. Progression and Trends in Virus from Influenza A to COVID-19: An Overview of Recent Studies. Viruses 2021;13:1145. [PMID: 34203647 DOI: 10.3390/v13061145] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
155 Kumar M, Kumari N, Thakur N, Bhatia SK, Saratale GD, Ghodake G, Mistry BM, Alavilli H, Kishor DS, Du X, Chung SM. A Comprehensive Overview on the Production of Vaccines in Plant-Based Expression Systems and the Scope of Plant Biotechnology to Combat against SARS-CoV-2 Virus Pandemics. Plants (Basel) 2021;10:1213. [PMID: 34203729 DOI: 10.3390/plants10061213] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
156 Zeyaullah M, AlShahrani AM, Muzammil K, Ahmad I, Alam S, Khan WH, Ahmad R. COVID-19 and SARS-CoV-2 Variants: Current Challenges and Health Concern. Front Genet 2021;12:693916. [PMID: 34211506 DOI: 10.3389/fgene.2021.693916] [Cited by in Crossref: 4] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
157 Oshiumi H. Circulating Extracellular Vesicles Carry Immune Regulatory miRNAs and Regulate Vaccine Efficacy and Local Inflammatory Response After Vaccination. Front Immunol 2021;12:685344. [PMID: 34211472 DOI: 10.3389/fimmu.2021.685344] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
158 Zhang Q, Xiang R, Huo S, Zhou Y, Jiang S, Wang Q, Yu F. Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy. Signal Transduct Target Ther 2021;6:233. [PMID: 34117216 DOI: 10.1038/s41392-021-00653-w] [Cited by in F6Publishing: 76] [Reference Citation Analysis]
159 Bertsimas D, Digalakis Jr V, Jacquillat A, Li ML, Previero A. Where to locate COVID ‐19 mass vaccination facilities? Naval Research Logistics 2022;69:179-200. [DOI: 10.1002/nav.22007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
160 Routhu NK, Cheedarla N, Bollimpelli VS, Gangadhara S, Edara VV, Lai L, Sahoo A, Shiferaw A, Styles TM, Floyd K, Fischinger S, Atyeo C, Shin SA, Gumber S, Kirejczyk S, Dinnon KH 3rd, Shi PY, Menachery VD, Tomai M, Fox CB, Alter G, Vanderford TH, Gralinski L, Suthar MS, Amara RR. SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lung. Nat Commun 2021;12:3587. [PMID: 34117252 DOI: 10.1038/s41467-021-23942-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 27] [Article Influence: 1.0] [Reference Citation Analysis]
161 Wu CH, Lin HH, Lai SY, Tseng KC, Hsu CH. A Study of Leisure Constraints and Job Satisfaction of Middle-Aged and Elderly Health Care Workers in COVID-19 Environment. Healthcare (Basel) 2021;9:713. [PMID: 34200864 DOI: 10.3390/healthcare9060713] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
162 Zhong Z. Controlled delivery systems are the cornerstone of advanced therapies and vaccines: An Asian perspective. J Control Release 2021;334:34-6. [PMID: 33872628 DOI: 10.1016/j.jconrel.2021.04.011] [Reference Citation Analysis]
163 Pereira-Silva M, Chauhan G, Shin MD, Hoskins C, Madou MJ, Martinez-Chapa SO, Steinmetz NF, Veiga F, Paiva-Santos AC. Unleashing the potential of cell membrane-based nanoparticles for COVID-19 treatment and vaccination. Expert Opin Drug Deliv 2021;:1-20. [PMID: 33944644 DOI: 10.1080/17425247.2021.1922387] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
164 Shin CH, Kim KH, Jeeva S, Kang SM. Towards Goals to Refine Prophylactic and Therapeutic Strategies Against COVID-19 Linked to Aging and Metabolic Syndrome. Cells 2021;10:1412. [PMID: 34204163 DOI: 10.3390/cells10061412] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
165 Bondarenko O, Saarma M. Neurotrophic Factors in Parkinson's Disease: Clinical Trials, Open Challenges and Nanoparticle-Mediated Delivery to the Brain. Front Cell Neurosci 2021;15:682597. [PMID: 34149364 DOI: 10.3389/fncel.2021.682597] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
166 Sarkis M, Bernardi A, Shah N, Papathanasiou MM. Decision support tools for next-generation vaccines and advanced therapy medicinal products: present and future. Current Opinion in Chemical Engineering 2021;32:100689. [DOI: 10.1016/j.coche.2021.100689] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
167 Sahu T, Ratre YK, Chauhan S, Bhaskar L, Nair MP, Verma HK. Nanotechnology based drug delivery system: Current strategies and emerging therapeutic potential for medical science. Journal of Drug Delivery Science and Technology 2021;63:102487. [DOI: 10.1016/j.jddst.2021.102487] [Cited by in Crossref: 2] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
168 Pujawan IN, Bah AU. Supply chains under COVID-19 disruptions: literature review and research agenda. Supply Chain Forum: An International Journal 2022;23:81-95. [DOI: 10.1080/16258312.2021.1932568] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
169 Lu L, Duong VT, Shalash AO, Skwarczynski M, Toth I. Chemical Conjugation Strategies for the Development of Protein-Based Subunit Nanovaccines. Vaccines (Basel) 2021;9:563. [PMID: 34071482 DOI: 10.3390/vaccines9060563] [Cited by in Crossref: 1] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
170 Niño MD, Hearne BN, Cai T. Trajectories of COVID-19 vaccine intentions among U.S. adults: The role of race and ethnicity. SSM Popul Health 2021;15:100824. [PMID: 34075337 DOI: 10.1016/j.ssmph.2021.100824] [Cited by in Crossref: 1] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
171 Valdes-Balbin Y, Santana-Mederos D, Paquet F, Fernandez S, Climent Y, Chiodo F, Rodríguez L, Sanchez Ramirez B, Leon K, Hernandez T, Castellanos-Serra L, Garrido R, Chen GW, Garcia-Rivera D, Rivera DG, Verez-Bencomo V. Molecular Aspects Concerning the Use of the SARS-CoV-2 Receptor Binding Domain as a Target for Preventive Vaccines. ACS Cent Sci 2021;7:757-67. [PMID: 34075345 DOI: 10.1021/acscentsci.1c00216] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 28.0] [Reference Citation Analysis]
172 Binzel DW, Li X, Burns N, Khan E, Lee WJ, Chen LC, Ellipilli S, Miles W, Ho YS, Guo P. Thermostability, Tunability, and Tenacity of RNA as Rubbery Anionic Polymeric Materials in Nanotechnology and Nanomedicine-Specific Cancer Targeting with Undetectable Toxicity. Chem Rev 2021;121:7398-467. [PMID: 34038115 DOI: 10.1021/acs.chemrev.1c00009] [Cited by in F6Publishing: 14] [Reference Citation Analysis]
173 Foladori G, Cypher JM. Pandemic Perspectives on Medicine and Militarism. International Critical Thought 2021;11:252-70. [DOI: 10.1080/21598282.2021.1924828] [Reference Citation Analysis]
174 Jennings BC, Kornfeld S, Doray B. A weak COPI binding motif in the cytoplasmic tail of SARS-CoV-2 spike glycoprotein is necessary for its cleavage, glycosylation, and localization. FEBS Lett 2021;595:1758-67. [PMID: 33991349 DOI: 10.1002/1873-3468.14109] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
175 Seifi T, Reza Kamali A. Antiviral performance of graphene-based materials with emphasis on COVID-19: A review. Med Drug Discov 2021;:100099. [PMID: 34056572 DOI: 10.1016/j.medidd.2021.100099] [Cited by in Crossref: 3] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
176 Hetherington E, Edwards SA, MacDonald SE, Racine N, Madigan S, McDonald S, Tough S. SARS-CoV-2 vaccination intentions among mothers of children aged 9 to 12 years: a survey of the All Our Families cohort. CMAJ Open 2021;9:E548-55. [PMID: 34021012 DOI: 10.9778/cmajo.20200302] [Cited by in Crossref: 4] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
177 Zhang F, Wang Z, Vijver MG, Peijnenburg WJGM. Probing nano-QSAR to assess the interactions between carbon nanoparticles and a SARS-CoV-2 RNA fragment. Ecotoxicol Environ Saf 2021;219:112357. [PMID: 34044308 DOI: 10.1016/j.ecoenv.2021.112357] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
178 Chiba S, Frey SJ, Halfmann PJ, Kuroda M, Maemura T, Yang JE, Wright ER, Kawaoka Y, Kane RS. Multivalent nanoparticle-based vaccines protect hamsters against SARS-CoV-2 after a single immunization. Commun Biol 2021;4:597. [PMID: 34011948 DOI: 10.1038/s42003-021-02128-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
179 Koike H, Katsuno M. Emerging infectious diseases, vaccines and Guillain-Barré syndrome. Clin Exp Neuroimmunol 2021. [PMID: 34230841 DOI: 10.1111/cen3.12644] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
180 Melchor-Martínez EM, Torres Castillo NE, Macias-Garbett R, Lucero-Saucedo SL, Parra-Saldívar R, Sosa-Hernández JE. Modern World Applications for Nano-Bio Materials: Tissue Engineering and COVID-19. Front Bioeng Biotechnol 2021;9:597958. [PMID: 34055754 DOI: 10.3389/fbioe.2021.597958] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
181 Salahshoori I, Mobaraki-asl N, Seyfaee A, Mirzaei Nasirabad N, Dehghan Z, Faraji M, Ganjkhani M, Babapoor A, Shadmehr SZ, Hamrang A. Overview of COVID-19 Disease: Virology, Epidemiology, Prevention Diagnosis, Treatment, and Vaccines. Biologics 2021;1:2-40. [DOI: 10.3390/biologics1010002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
182 Raoufi E, Bahramimeimandi B, Salehi-Shadkami M, Chaosri P, Mozafari MR. Methodical Design of Viral Vaccines Based on Avant-Garde Nanocarriers: A Multi-Domain Narrative Review. Biomedicines 2021;9:520. [PMID: 34066608 DOI: 10.3390/biomedicines9050520] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
183 Sharma A, Ahmed S, Kaur J, Chawla R, Rejeeth C. Exploring status of emergency drugs and vaccine development in Covid-19 pandemic: an update. Virusdisease 2021;:1-13. [PMID: 33969152 DOI: 10.1007/s13337-021-00684-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
184 Gupta A, Pradhan A, Maurya VK, Kumar S, Theengh A, Puri B, Saxena SK. Therapeutic approaches for SARS-CoV-2 infection. Methods 2021:S1046-2023(21)00126-2. [PMID: 33962011 DOI: 10.1016/j.ymeth.2021.04.026] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
185 Zeng C, Hou X, Bohmer M, Dong Y. Advances of nanomaterials-based strategies for fighting against COVID-19. View (Beijing) 2021;:20200180. [PMID: 34766161 DOI: 10.1002/VIW.20200180] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
186 Kumar R, Santa Chalarca CF, Bockman MR, Bruggen CV, Grimme CJ, Dalal RJ, Hanson MG, Hexum JK, Reineke TM. Polymeric Delivery of Therapeutic Nucleic Acids. Chem Rev 2021. [PMID: 33939409 DOI: 10.1021/acs.chemrev.0c00997] [Cited by in Crossref: 3] [Cited by in F6Publishing: 31] [Article Influence: 3.0] [Reference Citation Analysis]
187 Hwang W, Lei W, Katritsis NM, MacMahon M, Chapman K, Han N. Current and prospective computational approaches and challenges for developing COVID-19 vaccines. Adv Drug Deliv Rev 2021;172:249-74. [PMID: 33561453 DOI: 10.1016/j.addr.2021.02.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
188 Ruksakulpiwat S. The impact of COVID-19 on patients with stroke: an integrative review. JHR 2021. [DOI: 10.1108/jhr-12-2020-0615] [Reference Citation Analysis]
189 Zoratto N, Montanari E, Viola M, Wang J, Coviello T, Di Meo C, Matricardi P. Strategies to load therapeutics into polysaccharide-based nanogels with a focus on microfluidics: A review. Carbohydr Polym 2021;266:118119. [PMID: 34044935 DOI: 10.1016/j.carbpol.2021.118119] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
190 Nel AE, Miller JF. Nano-Enabled COVID-19 Vaccines: Meeting the Challenges of Durable Antibody Plus Cellular Immunity and Immune Escape. ACS Nano 2021;15:5793-818. [PMID: 33793189 DOI: 10.1021/acsnano.1c01845] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 16.0] [Reference Citation Analysis]
191 Koitabashi K, Nagumo H, Nakao M, Machida T, Yoshida K, Sakai-Kato K. Acidic pH-induced changes in lipid nanoparticle membrane packing. Biochim Biophys Acta Biomembr 2021;1863:183627. [PMID: 33901441 DOI: 10.1016/j.bbamem.2021.183627] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
192 Friedrichs S, Bowman DM. COVID-19 may become nanomedicine's finest hour yet. Nat Nanotechnol 2021;16:362-4. [PMID: 33854220 DOI: 10.1038/s41565-021-00901-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
193 Chen M, Rosenberg J, Cai X, Hsuan Lee AC, Shi J, Nguyen M, Wignakumar T, Mirle V, Edobor AJ, Fung J, Donington JS, Shanmugarajah K, Lin Y, Chang E, Randall G, Penaloza-MacMaster P, Tian B, Madariaga ML, Huang J. Nanotraps for the containment and clearance of SARS-CoV-2. Matter 2021;4:2059-82. [PMID: 33907732 DOI: 10.1016/j.matt.2021.04.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
194 Batiha GE, Zayed MA, Awad AA, Shaheen HM, Mustapha S, Herrera-Calderon O, Pagnossa JP, Algammal AM, Zahoor M, Adhikari A, Pandey I, Elazab ST, Rengasamy KRR, Cruz-Martins N, Hetta HF. Management of SARS-CoV-2 Infection: Key Focus in Macrolides Efficacy for COVID-19. Front Med (Lausanne) 2021;8:642313. [PMID: 33937285 DOI: 10.3389/fmed.2021.642313] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
195 Chen J, Gao K, Wang R, Wei GW. Prediction and mitigation of mutation threats to COVID-19 vaccines and antibody therapies. Chem Sci 2021;12:6929-48. [PMID: 34123321 DOI: 10.1039/d1sc01203g] [Cited by in Crossref: 6] [Cited by in F6Publishing: 32] [Article Influence: 6.0] [Reference Citation Analysis]
196 Schwestka J, Stoger E. Microparticles and Nanoparticles from Plants-The Benefits of Bioencapsulation. Vaccines (Basel) 2021;9:369. [PMID: 33920425 DOI: 10.3390/vaccines9040369] [Reference Citation Analysis]
197 Le DT, Müller KM. In Vitro Assembly of Virus-Like Particles and Their Applications. Life (Basel) 2021;11:334. [PMID: 33920215 DOI: 10.3390/life11040334] [Cited by in Crossref: 3] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
198 Park JW, Lagniton PNP, Liu Y, Xu RH. mRNA vaccines for COVID-19: what, why and how. Int J Biol Sci 2021;17:1446-60. [PMID: 33907508 DOI: 10.7150/ijbs.59233] [Cited by in Crossref: 2] [Cited by in F6Publishing: 54] [Article Influence: 2.0] [Reference Citation Analysis]
199 Volpatti LR, Wallace RP, Cao S, Raczy MM, Wang R, Gray LT, Alpar AT, Briquez PS, Mitrousis N, Marchell TM, Sasso MS, Nguyen M, Mansurov A, Budina E, Solanki A, Watkins EA, Schnorenberg MR, Tremain AC, Reda JW, Nicolaescu V, Furlong K, Dvorkin S, Yu SS, Manicassamy B, LaBelle JL, Tirrell MV, Randall G, Kwissa M, Swartz MA, Hubbell JA. Polymersomes decorated with SARS-CoV-2 spike protein receptor binding domain elicit robust humoral and cellular immunity. bioRxiv 2021:2021. [PMID: 33851166 DOI: 10.1101/2021.04.08.438884] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
200 Thi TTH, Suys EJA, Lee JS, Nguyen DH, Park KD, Truong NP. Lipid-Based Nanoparticles in the Clinic and Clinical Trials: From Cancer Nanomedicine to COVID-19 Vaccines. Vaccines (Basel) 2021;9:359. [PMID: 33918072 DOI: 10.3390/vaccines9040359] [Cited by in Crossref: 17] [Cited by in F6Publishing: 78] [Article Influence: 17.0] [Reference Citation Analysis]
201 Colombani T, Rogers ZJ, Eggermont LJ, Bencherif SA. Harnessing biomaterials for therapeutic strategies against COVID-19. Emergent Mater 2021;:1-10. [PMID: 33842840 DOI: 10.1007/s42247-021-00171-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
202 Yamoah MA, Thai PN, Zhang XD. Transgene Delivery to Human Induced Pluripotent Stem Cells Using Nanoparticles. Pharmaceuticals (Basel) 2021;14:334. [PMID: 33917388 DOI: 10.3390/ph14040334] [Reference Citation Analysis]
203 Li S, Guo X, Gao R, Sun M, Xu L, Xu C, Kuang H. Recent Progress on Biomaterials Fighting against Viruses. Adv Mater 2021;33:e2005424. [PMID: 33644954 DOI: 10.1002/adma.202005424] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
204 Cordeiro AS, Farsakoglu Y, Crecente-Campo J, de la Fuente M, González SF, Alonso MJ. Carboxymethyl-β-glucan/chitosan nanoparticles: new thermostable and efficient carriers for antigen delivery. Drug Deliv Transl Res 2021;11:1689-702. [PMID: 33797035 DOI: 10.1007/s13346-021-00968-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
205 Korkmaz E, Balmert SC, Sumpter TL, Carey CD, Erdos G, Falo LD Jr. Microarray patches enable the development of skin-targeted vaccines against COVID-19. Adv Drug Deliv Rev 2021;171:164-86. [PMID: 33539853 DOI: 10.1016/j.addr.2021.01.022] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 21.0] [Reference Citation Analysis]
206 Machhi J, Shahjin F, Das S, Patel M, Abdelmoaty MM, Cohen JD, Singh PA, Baldi A, Bajwa N, Kumar R, Vora LK, Patel TA, Oleynikov MD, Soni D, Yeapuri P, Mukadam I, Chakraborty R, Saksena CG, Herskovitz J, Hasan M, Oupicky D, Das S, Donnelly RF, Hettie KS, Chang L, Gendelman HE, Kevadiya BD. Nanocarrier vaccines for SARS-CoV-2. Adv Drug Deliv Rev 2021;171:215-39. [PMID: 33428995 DOI: 10.1016/j.addr.2021.01.002] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 34.0] [Reference Citation Analysis]
207 Vargason AM, Anselmo AC, Mitragotri S. The evolution of commercial drug delivery technologies. Nat Biomed Eng 2021. [PMID: 33795852 DOI: 10.1038/s41551-021-00698-w] [Cited by in Crossref: 9] [Cited by in F6Publishing: 95] [Article Influence: 9.0] [Reference Citation Analysis]
208 Sindhwani S, Chan WCW. Nanotechnology for modern medicine: next step towards clinical translation. J Intern Med 2021;290:486-98. [PMID: 33480120 DOI: 10.1111/joim.13254] [Cited by in Crossref: 5] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
209 Derakhshan MA, Amani A, Faridi-Majidi R. State-of-the-Art of Nanodiagnostics and Nanotherapeutics against SARS-CoV-2. ACS Appl Mater Interfaces 2021;13:14816-43. [PMID: 33779135 DOI: 10.1021/acsami.0c22381] [Cited by in Crossref: 2] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
210 Uttarilli A, Amalakanti S, Kommoju PR, Sharma S, Goyal P, Manjunath GK, Upadhayay V, Parveen A, Tandon R, Prasad KS, Dakal TC, Ben Shlomo I, Yousef M, Neerathilingam M, Kumar A. Super-rapid race for saving lives by developing COVID-19 vaccines. J Integr Bioinform 2021;18:27-43. [PMID: 33761582 DOI: 10.1515/jib-2021-0002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
211 Seo YB, Suh YS, Ryu JI, Jang H, Oh H, Koo BS, Seo SH, Hong JJ, Song M, Kim SJ, Sung YC. Soluble Spike DNA Vaccine Provides Long-Term Protective Immunity against SARS-CoV-2 in Mice and Nonhuman Primates. Vaccines (Basel) 2021;9:307. [PMID: 33804981 DOI: 10.3390/vaccines9040307] [Cited by in Crossref: 4] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
212 Cao J, Zaremba OT, Lei Q, Ploetz E, Wuttke S, Zhu W. Artificial Bioaugmentation of Biomacromolecules and Living Organisms for Biomedical Applications. ACS Nano 2021;15:3900-26. [PMID: 33656324 DOI: 10.1021/acsnano.0c10144] [Cited by in Crossref: 7] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
213 Mosselhy DA, Virtanen J, Kant R, He W, Elbahri M, Sironen T. COVID-19 Pandemic: What about the Safety of Anti-Coronavirus Nanoparticles? Nanomaterials (Basel) 2021;11:796. [PMID: 33808934 DOI: 10.3390/nano11030796] [Cited by in Crossref: 3] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
214 Mildner R, Hak S, Parot J, Hyldbakk A, Borgos SE, Some D, Johann C, Caputo F. Improved multidetector asymmetrical-flow field-flow fractionation method for particle sizing and concentration measurements of lipid-based nanocarriers for RNA delivery. Eur J Pharm Biopharm 2021;163:252-65. [PMID: 33745980 DOI: 10.1016/j.ejpb.2021.03.004] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
215 Unal MA, Bayrakdar F, Fusco L, Besbinar O, Shuck CE, Yalcin S, Erken MT, Ozkul A, Gurcan C, Panatli O, Summak GY, Gokce C, Orecchioni M, Gazzi A, Vitale F, Somers J, Demir E, Yildiz SS, Nazir H, Grivel JC, Bedognetti D, Crisanti A, Akcali KC, Gogotsi Y, Delogu LG, Yilmazer A. 2D MXenes with antiviral and immunomodulatory properties: A pilot study against SARS-CoV-2. Nano Today 2021;38:101136. [PMID: 33753982 DOI: 10.1016/j.nantod.2021.101136] [Cited by in Crossref: 4] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
216 Ahmed J, Alenezi H, Edirisinghe U, Edirisinghe M. Perspective: Covid-19; emerging strategies and material technologies. Emergent Mater 2021;:1-6. [PMID: 33748673 DOI: 10.1007/s42247-021-00173-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
217 Goel N, Ahmad R, Fatima H, Khare SK. New threatening of SARS-CoV-2 coinfection and strategies to fight the current pandemic. Med Drug Discov 2021;10:100089. [PMID: 33748740 DOI: 10.1016/j.medidd.2021.100089] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
218 Ortega-Rivera OA, Pokorski JK, Steinmetz NF. A single-dose, implant-based, trivalent virus-like particle vaccine against "cholesterol checkpoint" proteins. Adv Ther (Weinh) 2021;4:2100014. [PMID: 34541299 DOI: 10.1002/adtp.202100014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
219 Li Y, Bi Y, Xiao H, Yao Y, Liu X, Hu Z, Duan J, Yang Y, Li Z, Li Y, Zhang H, Ding C, Yang J, Li H, He Z, Liu L, Hu G, Liu S, Che Y, Wang S, Li Q, Lu S, Cun W. A novel DNA and protein combination COVID-19 vaccine formulation provides full protection against SARS-CoV-2 in rhesus macaques. Emerg Microbes Infect 2021;10:342-55. [PMID: 33555988 DOI: 10.1080/22221751.2021.1887767] [Cited by in Crossref: 9] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
220 Vivekanandhan K, Shanmugam P, Barabadi H, Arumugam V, Daniel Raj Daniel Paul Raj D, Sivasubramanian M, Ramasamy S, Anand K, Boomi P, Chandrasekaran B, Arokiyaraj S, Saravanan M. Emerging Therapeutic Approaches to Combat COVID-19: Present Status and Future Perspectives. Front Mol Biosci 2021;8:604447. [PMID: 33763450 DOI: 10.3389/fmolb.2021.604447] [Cited by in Crossref: 2] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
221 Jackson SE, Paul E, Brown J, Steptoe A, Fancourt D. Negative Vaccine Attitudes and Intentions to Vaccinate Against Covid-19 in Relation to Smoking Status: A Population Survey of UK Adults. Nicotine Tob Res 2021;23:1623-8. [PMID: 33751125 DOI: 10.1093/ntr/ntab039] [Cited by in Crossref: 5] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
222 Dönmüş B, Ünal S, Kirmizitaş FC, Türkoğlu Laçin N. Virus-associated ribozymes and nano carriers against COVID-19. Artif Cells Nanomed Biotechnol 2021;49:204-18. [PMID: 33645342 DOI: 10.1080/21691401.2021.1890103] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
223 Chung JY, Thone MN, Kwon YJ. COVID-19 vaccines: The status and perspectives in delivery points of view. Adv Drug Deliv Rev 2021;170:1-25. [PMID: 33359141 DOI: 10.1016/j.addr.2020.12.011] [Cited by in Crossref: 138] [Cited by in F6Publishing: 126] [Article Influence: 138.0] [Reference Citation Analysis]
224 Pushparajah D, Jimenez S, Wong S, Alattas H, Nafissi N, Slavcev RA. Advances in gene-based vaccine platforms to address the COVID-19 pandemic. Adv Drug Deliv Rev 2021;170:113-41. [PMID: 33422546 DOI: 10.1016/j.addr.2021.01.003] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 34.0] [Reference Citation Analysis]
225 Zheng Y, Wu J, Jiang H, Wang X. Gold nanoclusters for theranostic applications. Coordination Chemistry Reviews 2021;431:213689. [DOI: 10.1016/j.ccr.2020.213689] [Cited by in Crossref: 5] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
226 Fan Y, Yen CW, Lin HC, Hou W, Estevez A, Sarode A, Goyon A, Bian J, Lin J, Koenig SG, Leung D, Nagapudi K, Zhang K. Automated high-throughput preparation and characterization of oligonucleotide-loaded lipid nanoparticles. Int J Pharm 2021;599:120392. [PMID: 33639228 DOI: 10.1016/j.ijpharm.2021.120392] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
227 De P, Chakraborty I, Karna B, Mazumder N. Brief review on repurposed drugs and vaccines for possible treatment of COVID-19. Eur J Pharmacol 2021;898:173977. [PMID: 33639193 DOI: 10.1016/j.ejphar.2021.173977] [Cited by in Crossref: 4] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
228 Kumaravel V, Nair KM, Mathew S, Bartlett J, Kennedy JE, Manning HG, Whelan BJ, Leyland NS, Pillai SC. Antimicrobial TiO2 nanocomposite coatings for surfaces, dental and orthopaedic implants. Chem Eng J 2021;416:129071. [PMID: 33642937 DOI: 10.1016/j.cej.2021.129071] [Cited by in Crossref: 6] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]
229 Rhouati A, Teniou A, Badea M, Marty JL. Analysis of Recent Bio-/Nanotechnologies for Coronavirus Diagnosis and Therapy. Sensors (Basel) 2021;21:1485. [PMID: 33672772 DOI: 10.3390/s21041485] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
230 Ashraf MU, Kim Y, Kumar S, Seo D, Ashraf M, Bae YS. COVID-19 Vaccines (Revisited) and Oral-Mucosal Vector System as a Potential Vaccine Platform. Vaccines (Basel) 2021;9:171. [PMID: 33670630 DOI: 10.3390/vaccines9020171] [Cited by in Crossref: 7] [Cited by in F6Publishing: 28] [Article Influence: 7.0] [Reference Citation Analysis]
231 Wang Y, Zhang Z, Luo J, Han X, Wei Y, Wei X. mRNA vaccine: a potential therapeutic strategy. Mol Cancer 2021;20:33. [PMID: 33593376 DOI: 10.1186/s12943-021-01311-z] [Cited by in Crossref: 60] [Cited by in F6Publishing: 52] [Article Influence: 60.0] [Reference Citation Analysis]
232 Hoshino K, Maeshiro T, Nishida N, Sugiyama M, Fujita J, Gojobori T, Mizokami M. Transmission dynamics of SARS-CoV-2 on the Diamond Princess uncovered using viral genome sequence analysis. Gene 2021;779:145496. [PMID: 33588037 DOI: 10.1016/j.gene.2021.145496] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
233 Kyriakides TR, Raj A, Tseng TH, Xiao H, Nguyen R, Mohammed FS, Halder SS, Xu M, Wu MJ, Bao S, Sheu WC. Biocompatibility of nanomaterials and their immunological properties. Biomed Mater 2021. [PMID: 33578402 DOI: 10.1088/1748-605X/abe5fa] [Cited by in Crossref: 5] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
234 Ibrahim Fouad G. A proposed insight into the anti-viral potential of metallic nanoparticles against novel coronavirus disease-19 (COVID-19). Bull Natl Res Cent 2021;45:36. [PMID: 33564223 DOI: 10.1186/s42269-021-00487-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
235 Sadeghi R, Masoudi MR, Khanjani N. The commitment for fair distribution of COVID-19 vaccine among all countries of the world. Res Nurs Health 2021;44:266-7. [PMID: 33522613 DOI: 10.1002/nur.22112] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
236 Aldosari BN, Alfagih IM, Almurshedi AS. Lipid Nanoparticles as Delivery Systems for RNA-Based Vaccines. Pharmaceutics 2021;13:206. [PMID: 33540942 DOI: 10.3390/pharmaceutics13020206] [Cited by in Crossref: 15] [Cited by in F6Publishing: 45] [Article Influence: 15.0] [Reference Citation Analysis]
237 Wang J, Wang D, Zhang Y, Dong J. Synthesis and Biopharmaceutical Applications of Sugar-Based Polymers: New Advances and Future Prospects. ACS Biomater Sci Eng 2021;7:963-82. [PMID: 33523642 DOI: 10.1021/acsbiomaterials.0c01710] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
238 Park KS, Sun X, Aikins ME, Moon JJ. Non-viral COVID-19 vaccine delivery systems. Adv Drug Deliv Rev 2021;169:137-51. [PMID: 33340620 DOI: 10.1016/j.addr.2020.12.008] [Cited by in Crossref: 92] [Cited by in F6Publishing: 76] [Article Influence: 92.0] [Reference Citation Analysis]
239 Lobo-Galo N, Gálvez-Ruíz JC, Balderrama-Carmona AP, Silva-Beltrán NP, Ruiz-Bustos E. Recent biotechnological advances as potential intervention strategies against COVID-19. 3 Biotech 2021;11:41. [PMID: 33457170 DOI: 10.1007/s13205-020-02619-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
240 Mahrosh HS, Mustafa G. The COVID-19 puzzle: a global nightmare. Environ Dev Sustain 2021;:1-28. [PMID: 33551672 DOI: 10.1007/s10668-021-01224-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
241 Milane L, Amiji M. Clinical approval of nanotechnology-based SARS-CoV-2 mRNA vaccines: impact on translational nanomedicine. Drug Deliv Transl Res 2021;11:1309-15. [PMID: 33512669 DOI: 10.1007/s13346-021-00911-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 40] [Article Influence: 10.0] [Reference Citation Analysis]
242 Kumar S, Paul A, Chatterjee S, Pütz S, Nehra N, Wang DS, Nisar A, M Jennings C, Parekh SH. Effect of ambient temperature on respiratory tract cells exposed to SARS-CoV-2 viral mimicking nanospheres-An experimental study. Biointerphases 2021;16:011006. [PMID: 33706521 DOI: 10.1116/6.0000743] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
243 Chan SK, Du P, Ignacio C, Mehta S, Newton IG, Steinmetz NF. Biomimetic Virus-Like Particles as Severe Acute Respiratory Syndrome Coronavirus 2 Diagnostic Tools. ACS Nano 2021;15:1259-72. [PMID: 33237727 DOI: 10.1021/acsnano.0c08430] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 20.0] [Reference Citation Analysis]
244 Ramadon D, McCrudden MTC, Courtenay AJ, Donnelly RF. Enhancement strategies for transdermal drug delivery systems: current trends and applications. Drug Deliv Transl Res 2021. [PMID: 33474709 DOI: 10.1007/s13346-021-00909-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 39] [Article Influence: 11.0] [Reference Citation Analysis]
245 Ghazi H, Taher T, Alfadhul S, Al-mahmood S, Hassan S, Hamoudi T, Raheema R. ACCEPTANCE OF COVID-19 VACCINE AMONG GENERAL POPULATION IN IRAQ. IqNJM 2021;3:93-103. [DOI: 10.37319/iqnjm.3.1.9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
246 Aydogdu MO, Altun E, Chung E, Ren G, Homer-Vanniasinkam S, Chen B, Edirisinghe M. Surface interactions and viability of coronaviruses. J R Soc Interface 2021;18:20200798. [PMID: 33402019 DOI: 10.1098/rsif.2020.0798] [Cited by in Crossref: 7] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
247 Smith DM, Keller A. DNA Nanostructures in the Fight Against Infectious Diseases. Adv Nanobiomed Res 2021;:2000049. [PMID: 33615315 DOI: 10.1002/anbr.202000049] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
248 Park DH, Choi J, Piri A, Hwang J, Byeon JH. Nano-dry-salt deposition on electret nonwoven confers anticoronaviral effect while retaining aerosol filtration performance. Environ Sci : Nano 2021;8:2780-91. [DOI: 10.1039/d1en00369k] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
249 Zare M, Sillanpää M, Ramakrishna S. Essential role of quantum science and nanoscience in antiviral strategies for COVID-19. Mater Adv 2021;2:2188-99. [DOI: 10.1039/d1ma00060h] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
250 Zhang Q, Wu W, Zhang J, Xia X. Merits of the 'good' viruses: the potential of virus-based therapeutics. Expert Opin Biol Ther 2021;21:731-40. [PMID: 33322950 DOI: 10.1080/14712598.2021.1865304] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
251 ElBagoury M, Tolba MM, Nasser HA, Jabbar A, Elagouz AM, Aktham Y, Hutchinson A. The find of COVID-19 vaccine: Challenges and opportunities. J Infect Public Health 2021;14:389-416. [PMID: 33647555 DOI: 10.1016/j.jiph.2020.12.025] [Cited by in Crossref: 4] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
252 Doroudian M, O' Neill A, Mac Loughlin R, Prina-Mello A, Volkov Y, Donnelly SC. Nanotechnology in pulmonary medicine. Curr Opin Pharmacol 2021;56:85-92. [PMID: 33341460 DOI: 10.1016/j.coph.2020.11.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
253 . Nanomedicine and the COVID-19 vaccines. Nat Nanotechnol 2020;15:963. [PMID: 33247210 DOI: 10.1038/s41565-020-00820-0] [Cited by in Crossref: 47] [Cited by in F6Publishing: 68] [Article Influence: 23.5] [Reference Citation Analysis]
254 Wibowo D, Jorritsma SHT, Gonzaga ZJ, Evert B, Chen S, Rehm BHA. Polymeric nanoparticle vaccines to combat emerging and pandemic threats. Biomaterials 2021;268:120597. [PMID: 33360074 DOI: 10.1016/j.biomaterials.2020.120597] [Cited by in Crossref: 9] [Cited by in F6Publishing: 35] [Article Influence: 4.5] [Reference Citation Analysis]
255 Mufamadi MS. Nanotechnology shows promise for next-generation vaccines in the fight against COVID-19. MRS Bull 2020;45:981-2. [DOI: 10.1557/mrs.2020.307] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
256 Al-ahmady ZS, Ali-boucetta H. Nanomedicine & Nanotoxicology Future Could Be Reshaped Post-COVID-19 Pandemic. Front Nanotechnol 2020;2:610465. [DOI: 10.3389/fnano.2020.610465] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
257 Magnini VP, Crotts JC, Calvert E. The increased importance of competitor benchmarking as a strategic management tool during COVID-19 recovery. IHR 2020;35:280-92. [DOI: 10.1108/ihr-08-2020-0044] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
258 Bonam SR, Kotla NG, Bohara RA, Rochev Y, Webster TJ, Bayry J. Potential immuno-nanomedicine strategies to fight COVID-19 like pulmonary infections. Nano Today 2021;36:101051. [PMID: 33519949 DOI: 10.1016/j.nantod.2020.101051] [Cited by in Crossref: 24] [Cited by in F6Publishing: 31] [Article Influence: 12.0] [Reference Citation Analysis]
259 Tau N, Yahav D, Shepshelovich D. Vaccine safety - is the SARS-CoV-2 vaccine any different? Hum Vaccin Immunother 2021;17:1322-5. [PMID: 33270474 DOI: 10.1080/21645515.2020.1829414] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
260 Han HJ, Nwagwu C, Anyim O, Ekweremadu C, Kim S. COVID-19 and cancer: From basic mechanisms to vaccine development using nanotechnology. Int Immunopharmacol 2021;90:107247. [PMID: 33307513 DOI: 10.1016/j.intimp.2020.107247] [Cited by in Crossref: 11] [Cited by in F6Publishing: 31] [Article Influence: 5.5] [Reference Citation Analysis]
261 Almeida B, Nag OK, Rogers KE, Delehanty JB. Recent Progress in Bioconjugation Strategies for Liposome-Mediated Drug Delivery. Molecules 2020;25:E5672. [PMID: 33271886 DOI: 10.3390/molecules25235672] [Cited by in Crossref: 6] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
262 Gallo O, Locatello LG, Mazzoni A, Novelli L, Annunziato F. The central role of the nasal microenvironment in the transmission, modulation, and clinical progression of SARS-CoV-2 infection. Mucosal Immunol 2021;14:305-16. [PMID: 33244161 DOI: 10.1038/s41385-020-00359-2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 70] [Article Influence: 14.5] [Reference Citation Analysis]
263 Ma X, Zou F, Yu F, Li R, Yuan Y, Zhang Y, Zhang X, Deng J, Chen T, Song Z, Qiao Y, Zhan Y, Liu J, Zhang J, Zhang X, Peng Z, Li Y, Lin Y, Liang L, Wang G, Chen Y, Chen Q, Pan T, He X, Zhang H. Nanoparticle Vaccines Based on the Receptor Binding Domain (RBD) and Heptad Repeat (HR) of SARS-CoV-2 Elicit Robust Protective Immune Responses. Immunity 2020;53:1315-1330.e9. [PMID: 33275896 DOI: 10.1016/j.immuni.2020.11.015] [Cited by in Crossref: 46] [Cited by in F6Publishing: 89] [Article Influence: 23.0] [Reference Citation Analysis]
264 da Costa CBP, Martins FJ, da Cunha LER, Ratcliffe NA, Cisne de Paula R, Castro HC. COVID-19 and Hyperimmune sera: A feasible plan B to fight against coronavirus. Int Immunopharmacol 2021;90:107220. [PMID: 33302034 DOI: 10.1016/j.intimp.2020.107220] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
265 Shi N, Liu B, Liang N, Ma Y, Ge Y, Yi H, Wo H, Gu H, Kuang Y, Tang S, Zhao Y, Tong L, Liu S, Zhao C, Chen R, Bai W, Fan Y, Shi Z, Li L, Liu J, Gu H, Zhi Y, Wang Z, Li Y, Li H, Wang J, Jiao L, Tian Y, Xiong Y, Huo R, Zhang X, Bai J, Chen H, Chen L, Feng Q, Guo T, Hou Y, Hu G, Hu X, Hu Y, Huang J, Huang Q, Huang S, Ji L, Jin H, Lei X, Li C, Wu G, Li J, Li M, Li Q, Li X, Liu H, Liu J, Liu Z, Ma Y, Mao Y, Mo L, Na H, Wang J, Song F, Sun S, Wang D, Wang M, Wang X, Wang Y, Wang Y, Wu W, Wu L, Xiao Y, Xie H, Xu H, Xu S, Xue R, Yang C, Yang K, Yang P, Yuan S, Zhang G, Zhang J, Zhang L, Zhao S, Zhao W, Zheng K, Zhou Y, Zhu J, Zhu T, Li G, Wang W, Zhang H, Wang Y, Wang Y. Association between early treatment with Qingfei Paidu decoction and favorable clinical outcomes in patients with COVID-19: A retrospective multicenter cohort study. Pharmacol Res 2020;161:105290. [PMID: 33181320 DOI: 10.1016/j.phrs.2020.105290] [Cited by in Crossref: 7] [Cited by in F6Publishing: 35] [Article Influence: 3.5] [Reference Citation Analysis]
266 Zhou X, Jiang X, Qu M, Aninwene GE 2nd, Jucaud V, Moon JJ, Gu Z, Sun W, Khademhosseini A. Engineering Antiviral Vaccines. ACS Nano 2020;14:12370-89. [PMID: 33001626 DOI: 10.1021/acsnano.0c06109] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 13.0] [Reference Citation Analysis]
267 Chung YH, Beiss V, Fiering SN, Steinmetz NF. COVID-19 Vaccine Frontrunners and Their Nanotechnology Design. ACS Nano 2020;14:12522-37. [PMID: 33034449 DOI: 10.1021/acsnano.0c07197] [Cited by in Crossref: 163] [Cited by in F6Publishing: 155] [Article Influence: 81.5] [Reference Citation Analysis]
268 Bruynseels K. Responsible innovation in synthetic biology in response to COVID-19: the role of data positionality. Ethics Inf Technol 2020;:1-9. [PMID: 33132748 DOI: 10.1007/s10676-020-09565-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
269 Agrawal M, Saraf S, Saraf S, Murty US, Kurundkar SB, Roy D, Joshi P, Sable D, Choudhary YK, Kesharwani P, Alexander A. In-line treatments and clinical initiatives to fight against COVID-19 outbreak. Respir Med 2020;:106192. [PMID: 33199136 DOI: 10.1016/j.rmed.2020.106192] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
270 Wu J, Tang Y. Revisiting the Immune Balance Theory: A Neurological Insight Into the Epidemic of COVID-19 and Its Alike. Front Neurol 2020;11:566680. [PMID: 33178109 DOI: 10.3389/fneur.2020.566680] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
271 DeFrancesco L. Whither COVID-19 vaccines? Nat Biotechnol 2020;38:1132-45. [PMID: 32989315 DOI: 10.1038/s41587-020-0697-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 10.0] [Reference Citation Analysis]
272 Liu W, Zhu HL, Duan Y. Virus-, host-, immune-based targets for COVID-19 therapy. Drug Discov Today 2020;25:2071-3. [PMID: 33035666 DOI: 10.1016/j.drudis.2020.10.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
273 Smith E, Davis-Gardner ME, Garcia-Ordonez RD, Nguyen TT, Hull M, Chen E, Baillargeon P, Scampavia L, Strutzenberg T, Griffin PR, Farzan M, Spicer TP. High-Throughput Screening for Drugs That Inhibit Papain-Like Protease in SARS-CoV-2. SLAS Discov 2020;25:1152-61. [PMID: 33043784 DOI: 10.1177/2472555220963667] [Cited by in Crossref: 5] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
274 Flanagan KL, Best E, Crawford NW, Giles M, Koirala A, Macartney K, Russell F, Teh BW, Wen SC. Progress and Pitfalls in the Quest for Effective SARS-CoV-2 (COVID-19) Vaccines. Front Immunol 2020;11:579250. [PMID: 33123165 DOI: 10.3389/fimmu.2020.579250] [Cited by in Crossref: 24] [Cited by in F6Publishing: 40] [Article Influence: 12.0] [Reference Citation Analysis]
275 Zaheer T, Pal K, Zaheer I. Topical review on nano-vaccinology: Biochemical promises and key challenges. Process Biochem 2021;100:237-44. [PMID: 33013180 DOI: 10.1016/j.procbio.2020.09.028] [Cited by in Crossref: 8] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
276 Fara A, Mitrev Z, Rosalia RA, Assas BM. Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines. Open Biol. 2020;10:200160. [PMID: 32961074 DOI: 10.1098/rsob.200160] [Cited by in Crossref: 52] [Cited by in F6Publishing: 109] [Article Influence: 26.0] [Reference Citation Analysis]
277 Abbas M, Ovais M, Chen C. Phage capsid nanoparticles as multivalent inhibitors of viral infections. Sci Bull (Beijing) 2020;65:2050-2. [PMID: 32953198 DOI: 10.1016/j.scib.2020.09.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
278 Campos EVR, Pereira AES, de Oliveira JL, Carvalho LB, Guilger-Casagrande M, de Lima R, Fraceto LF. How can nanotechnology help to combat COVID-19? Opportunities and urgent need. J Nanobiotechnology 2020;18:125. [PMID: 32891146 DOI: 10.1186/s12951-020-00685-4] [Cited by in Crossref: 58] [Cited by in F6Publishing: 82] [Article Influence: 29.0] [Reference Citation Analysis]
279 Jones GW, Monopoli MP, Campagnolo L, Pietroiusti A, Tran L, Fadeel B. No small matter: a perspective on nanotechnology-enabled solutions to fight COVID-19. Nanomedicine (Lond) 2020;15:2411-27. [PMID: 32873192 DOI: 10.2217/nnm-2020-0286] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
280 Hassanzadeh P. Nanotheranostics against COVID-19: From multivalent to immune-targeted materials. J Control Release 2020;328:112-26. [PMID: 32882269 DOI: 10.1016/j.jconrel.2020.08.060] [Cited by in Crossref: 11] [Cited by in F6Publishing: 19] [Article Influence: 5.5] [Reference Citation Analysis]
281 Iravani S. Nano- and biosensors for the detection of SARS-CoV-2: challenges and opportunities. Mater Adv 2020;1:3092-103. [DOI: 10.1039/d0ma00702a] [Cited by in Crossref: 17] [Cited by in F6Publishing: 33] [Article Influence: 8.5] [Reference Citation Analysis]
282 [DOI: 10.1101/2020.11.17.20233213] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
283 [DOI: 10.1101/2020.10.28.20221853] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
284 [DOI: 10.1101/2020.10.09.334136] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
285 [DOI: 10.1101/2021.02.14.431117] [Cited by in Crossref: 37] [Cited by in F6Publishing: 8] [Reference Citation Analysis]